# The Response To Ajmaline Provocation in Healthy Subjects

> **NCT02933437** · PHASE2 · UNKNOWN · sponsor: **St George's, University of London** · enrollment: 100 (estimated)

## Conditions studied

- Brugada Syndrome
- Sudden Death

## Interventions

- **DRUG:** Ajmaline

## Key facts

- **NCT ID:** NCT02933437
- **Lead sponsor:** St George's, University of London
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-22
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02933437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02933437, "The Response To Ajmaline Provocation in Healthy Subjects". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT02933437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*